In 2023, the United States leads in male deaths from malignant pancreatic neoplasms, followed by Japan and Germany, while Luxembourg and Iceland reported the lowest numbers. The year-on-year data shows increased mortality for most countries, with significant rises in Brazil, South Korea, and Peru. Argentina and Estonia experienced declines. Over the past five years, CAGR reveals consistent growth trends, particularly in countries like Peru and Iceland.
Future trends to monitor include advancements in medical treatment and early detection, potential policy changes in healthcare systems, and the impact of lifestyle modifications like diet and smoking cessation on pancreatic cancer mortality rates.
Top countries in Pancreas Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 25,920 | 2023 | +2.09% | +2.26% | View data |
| 2 | 2 Japan | 20,000 | 2023 | +2.12% | +2.2% | View data |
| 3 | 3 Germany | 10,160 | 2023 | +1.84% | +2.03% | View data |
| 4 | 4 Brazil | 6,680 | 2023 | +3.48% | +3.99% | View data |
| 5 | 5 United Kingdom | 5,330 | 2023 | +1.64% | +1.46% | View data |
| 6 | 6 Spain | 4,110 | 2023 | +2.29% | +1.87% | View data |
| 7 | 7 South Korea | 3,800 | 2023 | +3.18% | +3.55% | View data |
| 8 | 8 Canada | 2,940 | 2023 | +1.84% | +1.87% | View data |
| 9 | 9 Poland | 2,510 | 2023 | +0.84% | +0.23% | View data |
| 10 | 10 Mexico | 2,420 | 2023 | +1.81% | +2.14% | View data |
